Literature DB >> 17960429

Early decision and psychosocial support intervention for men with localised prostate cancer: an integrated approach.

Suzanne K Steginga1, Megan Ferguson, Samantha Clutton, R A Frank Gardiner, David Nicol.   

Abstract

GOAL: Men diagnosed with prostate cancer experience high decision-related distress concurrent with cancer-related distress. Psycho-education, problem solving and decision support were integrated in a novel telephone-delivered supportive care intervention targeting men at diagnosis and assessed for feasibility.
MATERIALS AND METHODS: An exploratory single-group pre-post-test design tracked session frequency, duration and content. Standardised measures assessed decisional conflict, cancer-related distress and decision involvement. Brief screening measures for psychological and decision-related distress were incorporated into the intervention protocol. Twenty men (77% response) newly diagnosed with localised prostate cancer received the intervention.
RESULTS: Men who were undecided about treatment at study entry required more pre-treatment intervention calls (p < 0.013). Pre-treatment support calls were longer (M = 40.2 min) and more complex by comparison to post-treatment calls (M = 30.9 min; p < 0.002). Brief screening for decision-related distress correlated with concurrent (p < 0.008) and prospective (p < 0.046) decisional conflict. Decisional conflict and intrusion decreased at post-test (p < 0.001; p < 0.005). Men reported a high level of satisfaction with the support received with benefits identified including anonymity and accessibility.
CONCLUSIONS: In this setting, a tele-based supportive care and decision support intervention for men newly diagnosed with prostate cancer was feasible. The use of brief screening measures as within-intervention clinical tools appears promising.

Entities:  

Mesh:

Year:  2007        PMID: 17960429     DOI: 10.1007/s00520-007-0351-7

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  35 in total

1.  Videoconferencing for delivery of breast cancer support groups to women living in rural communities: a pilot study.

Authors:  Kate Collie; Mary Anne Kreshka; Susan Ferrier; Rebecca Parsons; Kathy Graddy; Speranza Avram; Patty Mannell; Xin-Hua Chen; James Perkins; Cheryl Koopman
Journal:  Psychooncology       Date:  2007-08       Impact factor: 3.894

2.  The Dutch cancer information helpline: experience and impact.

Authors:  L Lechner; H De Vries
Journal:  Patient Educ Couns       Date:  1996-07

3.  Validation of a decisional conflict scale.

Authors:  A M O'Connor
Journal:  Med Decis Making       Date:  1995 Jan-Mar       Impact factor: 2.583

4.  Preferences for involvement in medical decision-making: situational and demographic influences.

Authors:  S C Thompson; J S Pitts; L Schwankovsky
Journal:  Patient Educ Couns       Date:  1993-12-31

5.  The tiered model of psychosocial intervention in cancer: a community based approach.

Authors:  Sandy D Hutchison; Suzanne K Steginga; Jeff Dunn
Journal:  Psychooncology       Date:  2006-06       Impact factor: 3.894

6.  Low-income women with early-stage breast cancer: physician and patient decision-making styles.

Authors:  K L McVea; W C Minier; J E Johnson Palensky
Journal:  Psychooncology       Date:  2001 Mar-Apr       Impact factor: 3.894

7.  Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects: nurse-delivered psychoeducational intervention over the telephone.

Authors:  Merle H Mishel; Michael Belyea; Barbara B Germino; Janet L Stewart; Donald E Bailey; Cary Robertson; James Mohler
Journal:  Cancer       Date:  2002-03-15       Impact factor: 6.860

8.  Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions.

Authors:  Stephen J Lepore; Vicki S Helgeson; David T Eton; Richard Schulz
Journal:  Health Psychol       Date:  2003-09       Impact factor: 4.267

9.  Telephone social support and education for adaptation to prostate cancer: a pilot study.

Authors:  Kathleen Walsh Scura; Wendy Budin; Ellen Garfing
Journal:  Oncol Nurs Forum       Date:  2004 Mar-Apr       Impact factor: 2.172

10.  A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival.

Authors:  C Parker; D Muston; J Melia; S Moss; D Dearnaley
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640

View more
  5 in total

Review 1.  The decision-related psychosocial concerns of men with localised prostate cancer: targets for intervention and research.

Authors:  Suzanne K Steginga; Emma Turner; Jenny Donovan
Journal:  World J Urol       Date:  2008-06-12       Impact factor: 4.226

2.  Population-based study of grade progression in patients who harboured Gleason 3 + 3.

Authors:  Fanny Sampurno; Arul Earnest; Jeremy Millar; Mark Frydenberg; Declan Murphy; Warwick Delprado; Sue Evans
Journal:  World J Urol       Date:  2017-05-12       Impact factor: 4.226

3.  The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial.

Authors:  Donna L Berry; Barbara Halpenny; Fangxin Hong; Seth Wolpin; William B Lober; Kenneth J Russell; William J Ellis; Usha Govindarajulu; Jaclyn Bosco; B Joyce Davison; Gerald Bennett; Martha K Terris; Andrea Barsevick; Daniel W Lin; Claire C Yang; Greg Swanson
Journal:  Urol Oncol       Date:  2011-12-07       Impact factor: 3.498

4.  Men with prostate cancer over the first year of illness: their experiences as biographical disruption.

Authors:  Sandi Cayless; Liz Forbat; Nicola Illingworth; Gill Hubbard; Nora Kearney
Journal:  Support Care Cancer       Date:  2009-04-07       Impact factor: 3.603

5.  ProsCan for men: randomised controlled trial of a decision support intervention for men with localised prostate cancer.

Authors:  Suzanne K Chambers; Megan Ferguson; R A Gardiner; David Nicol; Louisa Gordon; Stefano Occhipinti; Joanne Aitken
Journal:  BMC Cancer       Date:  2008-07-24       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.